RT Journal Article
SR Electronic
T1 Quetiapine for primary insomnia: Consider the risks
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 286
OP 294
DO 10.3949/ccjm.88a.20031
VO 88
IS 5
A1 Vania Modesto-Lowe
A1 Agata K. Harabasz
A1 Sophia A. Walker
YR 2021
UL http://www.ccjm.org/content/88/5/286.abstract
AB The second-generation antipsychotic drug quetiapine (Seroquel) is increasingly being used off-label for treating insomnia in the general population, possibly to avoid standard medications with known addictive qualities and adverse side effects. However, evidence to support using it in this way is scant, and quetiapine is associated with weight gain and other metabolic effects. It must be used cautiously and with appropriate monitoring for adverse effects and abuse.